Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transcranial Direct Current Stimulation (tDCS) as a Cognitive Functioning Enhancement Treatment for ADHD Patients Compared to Healthy Controls

NCT04697316 is registered in ClinicalTrials.gov with Hebrew University of Jerusalem as lead sponsor.

NCT NCT04697316
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04697316 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transcranial Direct Current Stimulation (tDCS) as a Cognitive Functioning Enhancement Treatment for ADHD Patients Compared to Healthy Controls
Lead sponsor
Hebrew University of Jerusalem
Phase
Not applicable
Overall status
Completed
Start date
August 1, 2021
Completion date
June 1, 2023
Enrollment
63 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

transcranial direct current stimulation